Eintrag weiter verarbeiten
Buchumschlag von Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases
Verfügbar über Online-Ressource